Abstract

The treatment of postencephalitic parkinsonism was originated in 1926 by the Bulgarian plant collector Ivan Raeff. In a previous publication1it was pointed out that the only effective component of this medication is the Bulgarian belladonna root. PHARMACOLOGIC ASPECTS Belladonna roots have rarely been used for therapy. Atropine, hyoscyamine, scopolamine and other alkaloids of this group are usually extracted from the leaves of Atropa belladonna, Hyoscyamus niger, Datura stramonium, Scopolia atropoides or Duboisia myoporoides. In general, these alkaloids are found in roots and leaves, but in different concentrations and in different proportions of the individual alkaloids. Belladonna roots themselves show considerable variation in the concentration and distribution of the alkaloids, the variations depending on the age of the plant, the time of harvest, the geographic location, the climatic condition, the degree of cultivation and storage. For example, Raeff's original Bulgarian root contains 0.86 per cent of total alkaloids

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.